NSGENE A/S
Patent Owner
Stats
- 6 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- May 02, 2013 most recent publication
Details
- 6 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 174 Total Citation Count
- Jul 02, 1999 Earliest Filing
- 16 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
7655463 Methods of activating RET receptor tyrosine kinase using neurotrophic factorsFeb 12, 08Feb 02, 10[A61K, C12N, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2012/0021,039 EXPRESSION OF NEUROPEPTIDES IN MAMMALIAN CELLSAbandonedJan 21, 10Jan 26, 12[A61K, A61F, C12N, A61P]
2010/0234,293 Novel Neurotrophic FactorsAbandonedOct 27, 09Sep 16, 10[A61K, C07H, C12P, C12N, A61P, C07K]
2008/0318,853 Diagnostic and Therapeutic Use of a Novel Growth Factor, NeublasminAbandonedNov 04, 05Dec 25, 08[A61K, C12Q, C12P, C12N, G01N, C07K]
2008/0286,323 Human Therapeutic Cells Secreting Nerve Growth FactorAbandonedJan 18, 05Nov 20, 08[A61K, A61F, C12N, C12M, A61P]
2007/0128,168 Novel genes regulated in the developing human ventral mesencephalonAbandonedNov 15, 06Jun 07, 07[A61K, C12N, G01N]
2005/0221,392 Detection and isolation of cell populations from muscle using antibodies to fa1/dlk1AbandonedApr 27, 05Oct 06, 05[C12N, G01N]
2004/0241,170 Isolation of cells from neural cell populations using antibodies to fa1/dlk1AbandonedFeb 23, 04Dec 02, 04[A61K]
2004/0198,650 Means for inhibiting proteolytical processing of parkinAbandonedApr 12, 04Oct 07, 04[A61K, C12Q, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.